Upload
others
View
0
Download
0
Embed Size (px)
Citation preview
FILTER VISION PUBLIC COMPANY LIMITED
1
Opportunity Day : Q2.2019
August 23, 2019
At The Stock Exchange of Thailand
Disclaimer
2
The information contained in this presentation is for information purposes only and does not constitute an offer or invitation to
sell or the solicitation of an offer or invitation to purchase or subscribe for share in Filter Vision Public Company Limited
(“FVC” and shares in FVC “shares”) in any jurisdiction nor should it or any part of it form the basis of, or be relied upon in any
connection with, any contract or commitment whatsoever.
This presentation may include information which is forward-looking in nature. Forward-looking information involve known and
unknown risks, uncertainties and other factors which may impact on the actual outcomes, including economic conditions in
the markets in which FVC operates and general achievement of FVC business forecasts, which will cause the actual results,
performance or achievements of FVC to differ, perhaps materially, from the results, performance or achievements expressed
or implied in this presentation.
This presentation has been prepared by FVC. The information in this presentation has not been independently verified. No
representation, warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy,
completeness or correctness of the information and opinions in this presentation. None of FVC or any of its agents or
advisers, or any of their respective affiliates, advisers or representatives, shall have any liability (in negligence or otherwise)
for any loss howsoever arising from any use of this presentation or its contents or otherwise arising in connection with this
presentation.
This presentation is made, furnished and distributed for information purposes only. No part of this presentation shall be relied
upon directly or indirectly for any investment decision-making or for any other purposes.
This presentation and all other information, materials or documents provided in connection therewith, shall not, either in whole
or in part, be reproduced, redistributed or made available to any other person, save in strict compliance with all applicable
laws.
Contents
3
Business Overview
Financial Information
Strategy and Outlook
Q & A
Contents
4
Business Overview
Financial Information
Strategy and Outlook
Q & A
Business Overview
5
FVC distribute, design, assembly, install and preventive maintenance of water
treatment system and related products
Industrial & OEM
B1
Commercial & Residential
B2
Medical Service
B3
B3 (IRV) – Dialysis SOLN, Water and
Facility for Hemodialysis(HD) B3 (KTMS) – Hemodialysis Center
B3 (MV) – Pneumatic Tube System
B3 (HHC) – Healthcare and aesthetics
Business Overview
6
B1 : Industrial and OEM
Reverse Osmosis System
Automatic Regenerate
Softener Filter Semi Automatic Water Purifier
Zero Discharge Wastewater
Treatment System
Ultra Filtration
Bio-Well for Dental
Business Overview
7
B1 : Industrial and OEM
Auto Valves
Filter Cartridge &
Housing
Pressure Vessel
Fiberglass Tank
Business Overview
8
B2 : Commercial and residential
RO system + Everpure High
flow triple
Water system for drinking
water and ice machine
Nitro-Coffee
WATER INT PAD
UV System
Prefilter R30-BB+7FC
Triple+Claris L
Business Overview
9
B3 : Medical service
IRVING CORPORATION LIMITED
Dialyzer Cabinet
Dialysate Solution
Chemical Hood
Decoration for HD
Pure Water Treatment
System for HD
Business Overview
10
B3 : Medical service
KT MEDICAL SERVICE COMPANY LIMITED
KT Medical Service Hemodialysis Center
Business Overview
11
B3 : Medical service
MEDICAL VISION COMPANY LIMITED
Pneumatic Tube System
Business Overview
12
B3 : Medical service
HI HEALTHCARE CENTER COMPANY LIMITED
Healthcare and aesthetics clinic under trademark “Wuttisak Clinic”
Industrial & OEM (B1)
13
Customer Segments
Industrial & OEM (B1)
14
Customer Segments
Commercial & Residential (B2)
15
Customer Segments
Commercial & Residential (B2)
16
Customer Segments
Medical Service ( B3)
17
Customer Segments
18
Business Overview
Financial Information
Strategy and Outlook
Q & A
Content
B1
14%
B2
40%
B3
46%
Q2’18 Revenue Breakdown
Revenue (6M)
(Bt.mil) Q2’2018 (6M) Q2’2019 (6M) increase/
(decrease) %
B1 42.39 140.10 97.71 230.50%
B2 123.92 145.70 21.78 17.58%
B3 142.45 154.80 12.35 8.67%
Total 308.76 440.60 131.84 42.70% 19
Financial Information
Bt. mil
B1
32%
B2
33%
B3
35%
Q2’19 Revenue Breakdown
0
100
200
300
400
500
600
700
2014 2015 2016 2017 2018 Q2'2018 Q2'2019
360.75 364.91 394.31
459.26
656.71
308.76
440.60
Gross Profit Margin
YoY
4.65%
20
Financial Information
31.64%
27.21% 27.94% 28.59%
26.34%
19.11%
14.56%
19.21%
2013 2014 2015 2016 2017 2018 Q2'2018 Q2'2019
Gross Profit Margin
Q2’18 (6M) & Q2’19 (6M)
Personnel
50%
Traveling 2%
Office expense4%
Depreciation 5%
Professional 4%
Others
35%
Chart Title
AMOUNT
Q1'18 Q2'18 Q3'18 Q4'18 Q2'18 Q2'19
6.15 7.07 8.34 8.49 13.22
18.35
17.32 17.62 17.42 17.83
34.94
70.45
7.64 7.84 7.68 7.44
15.48
20.01
Selling Admin Management
SG&A (6M)
YoY
70.98%
Q2’19 (6M) SG&A Breakdown
(Bt.mil)
21
Financial Information
SG&A was increased by 70.98 % :
Mainly came from expenses which were
increased from HHC has recognize
allowance for doubtful debt in an
amounting of baht 31.98 MB
31.11 32.53 33.44 33.76
63.64
108.81 YoY
45.17
%
Net Profit & Net Profit Margin
(Bt.mil)
22
Net Loss (6M) was increased from Q2’18 around 1.38% mainly came from Hi Healthcare Center Co.,
Ltd. can’t generate income for cover expense while others business Example B1 & Hemodialysis
business still continuously growing up. However almost of loss was happened from allowance for
doubtful debt.
Financial Information
YoY
1.38%
YoY
10.76 (98.26%)
AMOUNT(6M)
(6.30)
(10.95)
(17.87)
(3.88)
(10.95)
(21.71)
-4.37%
-3.76%
-3.55%
-0.59%
-3.55%
-4.93%
-6.00%
-5.00%
-4.00%
-3.00%
-2.00%
-1.00%
0.00%
(25.00)
(15.00)
(5.00)
5.00
15.00
25.00
1Q18 2Q18 3Q18 4Q18 2Q18 2Q19
Net Profit Net Profit Margin
Margin
100
200
300
400
500
600
700
800
900
1000
2013 2014 2015 2016 2017 2018 Q2'19
275.40 285.95
407.05 466.93
787.13
954.82
1,016.09
203.44 208.98
336.33 358.99
663.70 671.07 643.70
71.96 76.97
70.72 107.94
123.43
283.75 372.39
Asset Equity Liabilities
Balance Sheet
(Bt.mil)
23
Financial Information
-3.82%
-3.30% -3.61%
-0.58% -0.58% -0.06%
-6.61%
1Q18 1Q18 3Q18 4Q18 4Q18 1Q19 2Q19
-3.11%
-2.63% -2.86%
-0.45% -0.45%
-0.04%
-4.41%
1Q18 2Q18 3Q18 4Q18 4Q18 1Q19 2 Q19
ROE
ROA
24
Financial Information
ROA & ROE were
decreased from Q'1
2019 mainly came
from Loss of
Group's business
however almost of
loss was happened
from allowance for
doubtful debt.
QoQ
4.37%
QoQ
6.55%
Q1’19(3M) & Q2’19 (3M)
D/E
25
Financial Information
0.27 0.32
0.34
0.42 0.42
0.58
1Q18 1Q18 3Q18 4Q18 4Q18 2Q19
change
0.16
26
Business Overview
Financial Information
Strategy and Outlook
Q & A
Content
27
FVC Road Map
Food & Beverage Medical Service
IPO on October 29, 2013.
2013
2014
2015
Restructure Technical Service
Department “Water Treatment” & “Food Equipment”.
- Capital Increased to 195 MB.
- Purchase land for new office and
warehouse (BKK).
Expand market to Medical Service
Sector .
28
FVC Road Map
2016
2017
2018
- Purchase land in Chiang Mai.
- Capital increased to 342.79 MB.
- Special project for discount store.
- Water treatment for dental.
- Capital Increased to 355.50 MB.
- Start with new office and warehouse (BKK).
- Launching New Products ; Water INT and Nitro
Coffee.
- Re-positioning in Industrial and OEM (B1)
- Recognize income from improve wastewater
treatment systems.
- Entered into franchisee of “Wuttisak Clinic”. - New Local Marketing & Operation in
healthcare and esthetics business.
- Exercise the 63 HD machines.
- Prepare the building in North to operate the
new hemodialysis center in 2019.
Operated Hemodialysis Center and
Pneumatic Tube System.
- Operated 2 new branch of Hemodialysis
Center.
- Capital increased to 40.00 MB. (KTMS)
- Entered MOU with “Wuttisak Clinic”.
Food & Beverage Medical Service
29
FVC Road Map
Corporate - Announce New Vision, Mission and Core Value.
- Implement the ERP system for business.
- Contract in wastewater treatment systems
(expected to be over than income budget).
- Recognized income from WATER INT PAD in North.
- Engagement in new organization for WATER INT PAD.
Food & Beverage
- Operated not less than 10 branches of hemodialysis
unit and exercise not less than 100 HD Machines.-
Recognized income from complete installation
Pneumatic Tube System for 6 projects in second
quarter.
- Expanding business in dialysis SOLN and water and
facility for hemodialysis(HD).
- Optimizing scale and strategy for healthcare and
aesthetics.
Medical Service
2019
Sale force management
Corporate
Balancing The Business’s Portfolio.
Uniformed Employer & Employee
Branding.
Supply Chain Mgmt. : Central
operation center, Utilities' Mgmt.
Projected to spin-off Medical Service
to mai in 2021.
30
FVC Road Map : Plan 2020 - 2022
B1
32%
B2
33%
B3
35%
Q2’19 Revenue Breakdown
Sale force management
31
FVC Road Map : Plan 2020 -2022
Sale Target : 150-200 MB. In 2022
Contractor and O&M for WTP and WWTP.
Green & Energy Saving Technology for
Special Application.
R & D resources for FVC.
B1
Industrial
& OEM
Sale force management
32
FVC Road Map : Plan 2020 -2022
Sale Target : 500.00 MB. In 2022.
Turned around knowledge base to be sale
(Value added).
The New Flagship ; WATER INT PAD /
Nitro Coffee / Food equipment.
Analysed the Big Data for New Product &
Service.
B2
Commercial
&
Residential
Sale force management
33
FVC Road Map : Plan 2020 -2022
Sale Target : 300.00 MB. In 2022.
Operation Synergised to Reducing Cost as well
as Standardized.
Increasing The Hemodialysis Operation (All
Products) : Forward & Backward Business.
Optimizing scale and strategy for healthcare
and aesthetics.
Exercise the 300 HD machines (approximate).
B3
Medical
Service
Sale force management
• Contactor + O&M : Trading (80:20).
• Green and energy saving technology.
B1
Industrial & OEM
• From base to be AR.
• Rolling value added to business partner.
• Finding New Ecosystem Man with Optimistic
B2
Commercial & Residential
• Medical engineering, Inspiration for hope (HD), and FVC employee branding (healthcare and aesthetics).
B3
Medical Service
34
Strategy and Outlook
35
Strategy and Outlook
o New Technology Product
o New Green& Environmental friendly
New Product Highlight
• Contractor + O&M : Trading (80:20). • Green and energy saving technology.
-------------------------------------------------------
• Project Management. • Sale force management.
B1
Industrial & OEM
36
Strategy and Outlook
Technology for Demineralized System and
Waste Water Recycle System.
• Ultrafiltration
• Reverse Osmosis
• Ion Exchange resin.
• EDI (Electrode ionization)
38
Water Treatment system
Alkaline Drinking Water System
40
Waste Water Treatment Plant
Tricking Filter System for Condensate Water Treatment.
Waste Water Treatment Plant
Sequencing Batch Reactor SBR
41
42
Waste Water Treatment
Renovated Water treatment system
Water Recycle Treatment system project
UV Disinfection for F&B
45
• From base to be AR.
• Rolling value added to business partner.
• Finding New Ecosystem Man with
Optimistic.
--------------------------------------------------------
• Business partners’ satisfaction. • Reinventing Organization.
B2
Commercial &
Residential
46
Strategy and Outlook
One System with all sanitation aspects
2015 V1 BES Group 47
COMMERCIAL - PORTABLE
AIR TREATMENT
OZONE GENERATOR
Green solution to odor control
Kill viruses, germs, bacteria
from hotel rooms, clinics,
homes, public spaces.
High Output, Hi-Efficiency Ultra
Long Life American made UV
Tube
On/Off switch with build-in LED
9 position electronic timer
Easily freshen a 100 m³ space
in 10 minutes, and a 2,200 m³ space in about 2 hours or less.
INNOVATION that increase an efficiency of air
conditioning system.
• Reduces condensing unit temperature
• Increase performance of the system
• Conserve electrical consumption ≥ 20%
• Reduce system working hours
• Increase condensing unit life time
• Control module with protection sensor
• Remote monitoring via mobile phone (optional)
• Medical engineering, Inspiration for hope (HD), and FVC employee branding (healthcare and aesthetics). -------------------------------------------------------------
• Strategy re-positioning in subsidiaries. • Medical standard competency.
B3
Medical Service
50
Strategy and Outlook
51
New Product Highlight
Pneumatic Tube Carrier System
52
Hemodialysis Center
New Product Highlight
53
New Product Highlight
Healthcare and aesthetics clinic under trademark “Wuttisak Clinic”
54
Business Overview
Financial Information
Strategy and Outlook
Q & A
Content
55